XML 63 R14.htm IDEA: XBRL DOCUMENT
v3.20.1

Fair Value Measurements and Investments | 6 Months Ended
--- | ---
Mar. 31, 2020
Fair Value Disclosures [Abstract] |
Fair Value Measurements and Investments | Note 6—Fair Value Measurements and Investments Assets and Liabilities Measured at Fair Value on a Recurring Basis
| Fair Value Measurements Using Inputs Considered as
| Level 1 |  | Level 2
| March 31, 2020 |  | September 30, 2019 |  | March 31, 2020 |  | September 30, 2019
| (in millions)
Assets |  |  |  |  |  |  |
Cash equivalents and restricted cash equivalents: |  |  |  |  |  |  |
Money market funds | $ | 8,864 |  |  | $ | 6,494 |  |  |  |  |
U.S. government-sponsored debt securities |  |  |  |  | $ | — |  |  | $ | 150 |
Investment securities: |  |  |  |  |  |  |
Marketable equity securities | 121 |  |  | 126 |  |  |  |  |
U.S. government-sponsored debt securities |  |  |  |  | 3,149 |  |  | 5,592 |
U.S. Treasury securities | 205 |  |  | 675 |  |  |  |  |
Other current and non-current assets: |  |  |  |  |  |  |
Derivative instruments |  |  |  |  | 768 |  |  | 437 |
Total | $ | 9,190 |  |  | $ | 7,295 |  |  | $ | 3,917 |  |  | $ | 6,179 |
Liabilities |  |  |  |  |  |  |
Accrued compensation and benefits: |  |  |  |  |  |  |
Deferred compensation liability | $ | 111 |  |  | $ | 113 |  |  |  |  |
Accrued and other liabilities: |  |  |  |  |  |  |
Derivative instruments |  |  |  |  | $ | 272 |  |  | $ | 52 |
Total | $ | 111 |  |  | $ | 113 |  |  | $ | 272 |  |  | $ | 52 |
There were no transfers between Level 1 and Level 2 assets during the six months ended March 31, 2020. Level 1 assets. Money market funds, marketable equity securities and U.S. Treasury securities are classified as Level 1 within the fair value hierarchy, as fair value is based on quoted prices in active markets. The Company’s deferred compensation liability is measured at fair value based on marketable equity securities held under the deferred compensation plan. Level 2 assets and liabilities. The fair value of U.S. government-sponsored debt securities, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. The pricing data obtained from outside sources is reviewed internally for reasonableness, compared against benchmark quotes from independent pricing sources, then confirmed or revised accordingly. Derivative instruments are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. There were no substantive changes to the valuation techniques and related inputs used to measure fair value during the six months ended March 31, 2020. U.S. government-sponsored debt securities and U.S. Treasury securities. The Company considers U.S. government-sponsored debt securities and U.S. Treasury securities to be available-for-sale and held $3.4 billion and $6.3 billion of these investment securities as of March 31, 2020 and September 30, 2019, respectively. All of the Company’s long-term available-for-sale investment securities are due within one to five years. Assets Measured at Fair Value on a Non-recurring Basis Non-marketable equity securities. The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. These investments are classified as Level 3 due to the absence of quoted market prices, the inherent lack of liquidity and the fact that inputs used to measure fair value are unobservable and require management’s judgment. During the three months ended March 31, 2020, the Company recorded no material upward or downward adjustments. During the six months ended March 31, 2020, $9 million of upward adjustments and no material downward adjustments were included in the carrying value of non-marketable equity securities. During the three and six months ended March 31, 2020 and 2019, there were no impairments. The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of March 31, 2020 including cumulative unrealized gains and losses:
| March 31, 2020
| (in millions)
Initial cost basis | $ | 611 |
Upward adjustments | 119 |
Downward adjustments (including impairment) | (5 | )
Carrying amount, end of period | $ | 725 |
Non-financial assets and liabilities. Long-lived assets such as goodwill, indefinite-lived intangible assets, finite-lived intangible assets and property, equipment and technology are considered non-financial assets. The Company does not have any non-financial liabilities measured at fair value on a non-recurring basis. Finite-lived intangible assets primarily consist of customer relationships and trade names, all of which were obtained through acquisitions. If the Company were required to perform a quantitative assessment for impairment testing of goodwill and indefinite-lived intangible assets, the fair values would generally be estimated using an income approach. As the assumptions employed to measure these assets on a non-recurring basis are based on management’s judgment using internal and external data, these fair value determinations are classified as Level 3 in the fair value hierarchy. The Company completed its annual impairment review of its indefinite-lived intangible assets and goodwill as of February 1, 2020, and concluded that there was no impairment. No recent events or changes in circumstances indicate that impairment existed at March 31, 2020. Gains and Losses on Marketable and Non-marketable Equity Securities Gains and losses on the Company’s equity securities are summarized below.
| Three Months Ended March 31, |  | Six Months Ended March 31,
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in millions)
Net gain (loss) on equity securities sold during the period | $ | 1 |  |  | $ | 15 |  |  | $ | 5 |  |  | $ | 15 |
Unrealized gain (loss) on equity securities held as of the end of the period | (23 | ) |  | 79 |  |  | (9 | ) |  | 59 |
Total gain (loss) recognized in non-operating income (expense), net | $ | (22 | ) |  | $ | 94 |  |  | $ | (4 | ) |  | $ | 74 |
Other Fair Value Disclosures Long-term debt. Debt instruments are measured at amortized cost on the Company’s consolidated balance sheets. The fair value of the debt instruments, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. The pricing data obtained from outside sources is reviewed internally for reasonableness, compared against benchmark quotes from independent pricing sources, then confirmed or revised accordingly. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy. The carrying value and estimated fair value of long-term debt was $16.9 billion and $18.6 billion, respectively, as of March 31, 2020. The carrying value and estimated fair value of long-term debt was $16.7 billion and $18.4 billion, respectively, as of September 30, 2019. Other financial instruments not measured at fair value. The following financial instruments are not measured at fair value on the Company’s unaudited consolidated balance sheet at March 31, 2020, but disclosure of their fair values is required: settlement receivable and payable, accounts receivable, commercial paper and customer collateral. The estimated fair value of such instruments at March 31, 2020 approximates their carrying value due to their generally short maturities. If measured at fair value in the financial statements, these financial instruments would be classified as Level 2 in the fair value hierarchy.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration